Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RAD. THERAPY PLANNING SUP. SYS.

K-Number: K772305 · 1978-01-09

ApplicantOhio Nuclear, Inc.
Decision Date1978-01-09
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

RAD. THERAPY PLANNING SUP. SYS. is the device name listed in this FDA 510(k) record. The listed applicant is Ohio Nuclear, Inc.. It received FDA 510(k) clearance on 1978-01-09 under 510(k) number K772305. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RAD. THERAPY PLANNING SUP. SYS.?

RAD. THERAPY PLANNING SUP. SYS. is a medical device that received FDA 510(k) clearance on 1978-01-09. The listed applicant is Ohio Nuclear, Inc.. The 510(k) number is K772305.

When did RAD. THERAPY PLANNING SUP. SYS. receive FDA 510(k) clearance?

RAD. THERAPY PLANNING SUP. SYS. received FDA 510(k) clearance on 1978-01-09, under 510(k) number K772305.

Who is the listed applicant for RAD. THERAPY PLANNING SUP. SYS.?

The FDA 510(k) record lists Ohio Nuclear, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RAD. THERAPY PLANNING SUP. SYS.?

The FDA product code for RAD. THERAPY PLANNING SUP. SYS. is JAK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Ohio Nuclear, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K792603COMPUTED TOMOGRAPHY X-RAY SCANNERK791195DELTASCAN COMPUTER TOMOGRAPHY X-RAY SCANK781079SONOGRAF ULTRASOUND B-SCANNING SYSTEMK780165PROCESSOR, VIDEO IMAGE VIP-550K780115SCANNERS, TOMOGRAPHIC, COMPUTEDK771082DELTASCAN 2000 SERIES

View all 7 devices →

Related Devices (Code: JAK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261125BodyTom 64 (NL4100); OmniTom Elite (NL5000)Samsung HME America, Inc., dba NeuroLogica Corp.K261229SCENARIA View Phase 6.0Fujifilm CorporationK253836FCT iStream Phase 2Fujifilm CorporationK253450BodyTom Elite (NL4000)NeuroLogica Corp., a Samsung CompanyK253770CardIQ SuiteGE Medical Systems SCSK253560Enhanced Boundary for PCCTGe Medical Systems, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑